Press Releases Keyword Search Year None202420232022202120202019201820172016201520142013 May 8, 2024 Editas Medicine Announces First Quarter 2024 Results and Business Updates May 2, 2024 Editas Medicine Announces First Quarter 2024 Results Conference Call and Upcoming Investor Events May 1, 2024 Editas Medicine and Bristol Myers Squibb Extend Alpha-Beta T Cell Collaboration April 22, 2024 Editas Medicine to Present Pre-clinical Data Demonstrating Progression of in vivo Medicines Pipeline at the American Society of Gene and Cell Therapy Annual Meeting February 28, 2024 Editas Medicine Announces Fourth Quarter and Full Year 2023 Results and Business Updates February 21, 2024 Editas Medicine Announces Fourth Quarter and Full Year 2023 Results Conference Call and Upcoming Investor Events January 31, 2024 Editas Medicine to Participate in Upcoming Investor Conferences January 8, 2024 Editas Medicine Highlights 2024 Anticipated Milestones and Strategic Priorities at the J.P. Morgan Healthcare Conference January 3, 2024 Editas Medicine to Present at the 42nd Annual J.P. Morgan Healthcare Conference Pagination First page « first Previous page ‹ previous Page 1 Current page 2
May 2, 2024 Editas Medicine Announces First Quarter 2024 Results Conference Call and Upcoming Investor Events
April 22, 2024 Editas Medicine to Present Pre-clinical Data Demonstrating Progression of in vivo Medicines Pipeline at the American Society of Gene and Cell Therapy Annual Meeting
February 28, 2024 Editas Medicine Announces Fourth Quarter and Full Year 2023 Results and Business Updates
February 21, 2024 Editas Medicine Announces Fourth Quarter and Full Year 2023 Results Conference Call and Upcoming Investor Events
January 8, 2024 Editas Medicine Highlights 2024 Anticipated Milestones and Strategic Priorities at the J.P. Morgan Healthcare Conference
